4-amino-2-(S-cysteinyl)butyric acid (ACBA)
from urine of patients with maple syrup urine disease
Also Known As:
ACBA; Butanoic acid, 4-amino-2-((2-amino-2-carboxyethyl)thio)-
Networked: 3
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Chen, Jerry Yongqiang:
1 article
(04/2022)
|
| 2. | Lim, Jason Beng Teck:
1 article
(04/2022)
|
| 3. | Liow, Lincoln Ming Han:
1 article
(04/2022)
|
| 4. | Padki, Akshay:
1 article
(04/2022)
|
| 5. | Purnomo, Glen:
1 article
(04/2022)
|
| 6. | Vemula, Vishnu:
1 article
(04/2022)
|
| 7. | Yeo, Seng Jin:
1 article
(04/2022)
|
| 8. | Bols, N C:
1 article
(10/2017)
|
| 9. | Dixon, B:
1 article
(10/2017)
|
| 10. | Li, A R:
1 article
(10/2017)
|
Related Diseases
| 1. | Pain (Aches)
07/01/2023
- " Our study found no significant differences when comparing ACBS and ACBA by POD1 pain score, ambulation distance, range of motion, and LOS. " 07/01/2023
- " The aim of our study was to compare postoperative day 1 (POD1) pain scores, ambulation distance, range of motion, active straight leg raise (SLR), and length of stay (LOS) in TKA patients receiving no ACB (NACB), ACB by surgeon (ACBS), or ACB by anesthetist (ACBA). " 07/01/2023
- " For the POD1 pain score after therapy, the NACB group scored 4.9 ± 3.1 compared with 3.5 ± 2.2 and 3.9 ± 1.8 scored by the ACBA and ACBS groups, respectively (p = 0.302). "
|
| 2. | Sepsis (Septicemia)
|
| 3. | Virus Diseases (Viral Diseases)
|
|
Related Therapies and Procedures